Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignanciesSanmei Wang(Heidelberg University), Maria‐Luisa Schubert(Heidelberg University)Oncology ReportsJune 23, 202110.3892/or.2021.8121Cited by 35SaveCiteExport RISWatch citationsRelated PapersA non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy|Nature Medicine|2023|226